Additionally, high expression of PD-L1 on tumors serves as a negative marker for bispecific antibodies because, despite the proximity of T cells to cancer cells, the interaction between PD-1 and PD-L1 prevents T cell activation. This evidence concerns the gene CD274 and cancer.